Neil Campbell, President and Chief Executive Officer of Helomics, will provide an overview of the personalized healthcare landscape, the Company’s business and its comprehensive tumor profiling technologies during his presentation and will be available to participate in one-on-one meetings. read more
The next generation in Personalized Healthcare™
Personalized healthcare should be comprehensive, precise, predictive, but most importantly, personal.
We believe that each patient is unique, and their cancer treatment should be too.
Helomics' ongoing array of multiple products and technologies provide unique clinical value through a Comprehensive Tumor Profile.
peer reviewed publications and
abstracts on ChemoFx
gynecologic cancer specimens received for ChemoFx testing
physicians have sent for ChemoFx testing
unique sets of gynecologic cancer cell specimens in our Biorepository